TrialJournal of pharmacokinetics and pharmacodynamics2010

A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate.

Chuanpu Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.